- Home
- TEX vs MRUS Comparison
TEX vs MRUS Comparison
Compare TEX & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEX
- MRUS
- Stock Information
- Founded
- TEX 1933
- MRUS 2003
- Country
- TEX United States
- MRUS Netherlands
- Employees
- TEX N/A
- MRUS N/A
- Industry
- TEX Construction/Ag Equipment/Trucks
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- TEX Industrials
- MRUS Health Care
- Exchange
- TEX Nasdaq
- MRUS Nasdaq
- Market Cap
- TEX 2.4B
- MRUS 2.7B
- IPO Year
- TEX N/A
- MRUS 2016
- Fundamental
- Price
- TEX $41.20
- MRUS $40.90
- Analyst Decision
- TEX Hold
- MRUS Strong Buy
- Analyst Count
- TEX 11
- MRUS 14
- Target Price
- TEX $46.40
- MRUS $87.00
- AVG Volume (30 Days)
- TEX 880.8K
- MRUS 770.0K
- Earning Date
- TEX 05-02-2025
- MRUS 05-07-2025
- Dividend Yield
- TEX 1.65%
- MRUS N/A
- EPS Growth
- TEX N/A
- MRUS N/A
- EPS
- TEX 3.67
- MRUS N/A
- Revenue
- TEX $5,064,000,000.00
- MRUS $54,732,000.00
- Revenue This Year
- TEX $4.25
- MRUS $26.81
- Revenue Next Year
- TEX $4.00
- MRUS $23.85
- P/E Ratio
- TEX $11.19
- MRUS N/A
- Revenue Growth
- TEX N/A
- MRUS 42.77
- 52 Week Low
- TEX $31.53
- MRUS $33.19
- 52 Week High
- TEX $68.08
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- TEX 63.19
- MRUS 45.06
- Support Level
- TEX $38.52
- MRUS $37.92
- Resistance Level
- TEX $41.35
- MRUS $46.36
- Average True Range (ATR)
- TEX 1.59
- MRUS 2.58
- MACD
- TEX 0.80
- MRUS -0.27
- Stochastic Oscillator
- TEX 95.45
- MRUS 35.31
About TEX Terex Corporation
Terex Corp is a manufacturer of materials processing machinery, waste and recycling solutions, mobile elevating work platforms (MEWPs), and equipment for the electric utility industry. The company designs builds, and supports products used in maintenance, manufacturing, energy, waste and recycling, minerals and materials management, construction, and the entertainment industry. The products are manufactured in North America, Europe, and Asia Pacific and sold all over the world. The company reports business in the following segments: (i) Materials Processing, (ii) Aerial Work Platforms, and (iii) Environmental Solutions Group.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.